Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare monoclonalgammopathy characterized by renal proximal tubule dysfunction secondary to monoclonal kappa light chain deposits in proximal tubular cells. Clinical presentation is with variable chronic kidney disease, low molecular weight proteinuria, aminoaciduria, hyperphosphaturia, uricosuria, bicarbonaturia, and non-diabetic glycosuria. Renal phosphate and urate wasting may cause hypophosphatemia and hypouricaemia.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for acquired monoclonal Ig light chain-associated Fanconi syndrome.
1 publication has been identified in PubMed for acquired monoclonal Ig light chain-associated Fanconi syndrome. Research spans Basic Science / Preclinical (100%).
Martinez-Rivas G (2025). [PMID: 40148271](https://pubmed.ncbi.nlm.nih.gov/40148271/). *Nature communications*. [Basic Science / Preclinical]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 3:17 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about acquired monoclonal Ig light chain-associated Fanconi syndrome